Chemotherapy before radiation for new high-grade glioma
Part of Brain & nervous system, Cancer clinical trials.
This study is testing whether a short course of chemotherapy (temozolomide) given before radiation can improve outcomes for people with newly diagnosed high-grade gliomas. It is designed for patients who are stable enough to delay starting radiation by a few weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a fast-growing type of brain tumor (high-grade glioma).
- You still have some tumor visible on a scan after surgery.
- You do not need radiation or chemotherapy right away due to brain swelling.
- You are between 18 and 80 years old.
- Your general health and ability to do daily tasks is at least 70% on a Karnofsky scale.
- Your blood counts and kidney/liver function are within a safe range.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding temozolomide chemotherapy after radiation helps control a type of low-grade brain tumor that was not fully removed. It may help reduce the chance the tumor comes back, compared with standard post-radiation care.
This study compares a standard radiation schedule versus a shorter, higher-dose radiation schedule, both with the chemotherapy medicine temozolomide, in older adults with newly diagnosed glioblastoma. It aims to see which approach works better and is practical for people age 70 and older.
This early-phase study tests whether liposomal curcumin, added to standard radiation plus temozolomide, can improve treatment outcomes in newly diagnosed high-grade gliomas. It focuses on safety and how well the treatment can be given with the usual therapy plan.
This trial tests giving radiation and chemotherapy before surgery for glioblastoma. It aims to see if this approach is safe and may help improve outcomes for patients whose tumor can be completely removed.
This trial tests whether a type of chemotherapy called anthracycline can help young patients with glioblastoma when given after radiation therapy. It aims to see if this treatment improves outcomes for patients aged 3 to 30.
This trial tests whether adding the study drug azeliragon to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma. The study will also look at how the tumor responds to the added drug.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.